N04BA02 levodopa and decarboxylase inhibitor
ATC group of level 5 – chemical substance · in plain English: medicines for Parkinson's disease
This site has the patient leaflet or the SPC of 40 medicines in this group.
- 28 prescription only (POM)
- 3 no longer supplied or not available
Place in the ATC classification
- N Nervous system drugs 4,479 medicines
- N04 Anti-parkinson drugs 315 medicines
- N04B Dopaminergic agents 292 medicines
- N04BA Dopa and dopa derivatives 83 medicines
- N04BA02 levodopa and decarboxylase inhibitor 40 medicines
- N04BA Dopa and dopa derivatives 83 medicines
- N04B Dopaminergic agents 292 medicines
- N04 Anti-parkinson drugs 315 medicines
Active substances in the group
- Benserazide hydrochloride 9 medicines
- Carbidopa 29 medicines
- Levodopa 40 medicines
Medicines
Other groups of the same level
- N04BA01 levodopa 2 medicines
- N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor 41 medicines
Other names of the ATC group
- Czech: N04BA02 Levodopa a inhibitor dekarboxylasy
- French: N04BA02 lévodopa et inhibiteur de la décarboxylase
- German: N04BA02 Levodopa und Decarboxylasehemmer*
- Spanish: N04BA02 LEVODOPA+INHIBIDOR DECARBOXILASA
- German: N04BA02 Levodopa und Decarboxylasehemmer*
- Italian: N04BA02
- Polish: N04BA02 INHIBITOR LEWODOPY I DEKARBOKSYLAZY
- Turkish: N04BA02 levodopa ve dekarboksilaz inhibitörü
- Portuguese (Brazil): N04BA02 Levodopa + Inibidor de decarboxilase
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N04BA02
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
